Xeris Biopharma Holdings, Inc. - Common Stock (XERS)
3.5600
-0.1000 (-2.73%)
Xeris Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for patients with chronic diseases and conditions
Utilizing its proprietary technology platforms, the company aims to enhance the delivery of injectable medications, creating formulations that are designed to be more convenient and effective for patients. Xeris is dedicated to addressing unmet medical needs by bringing forward products that can improve treatment experiences and outcomes for individuals with conditions such as diabetes and other specialty therapy needs.
Frequently Asked Questions
Is Xeris Biopharma Holdings, Inc. - Common Stock publicly traded?
Yes, Xeris Biopharma Holdings, Inc. - Common Stock is publicly traded.
What exchange does Xeris Biopharma Holdings, Inc. - Common Stock trade on?
Xeris Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock?
The ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock is XERS on the Nasdaq Stock Market
What is the current price of Xeris Biopharma Holdings, Inc. - Common Stock?
The current price of Xeris Biopharma Holdings, Inc. - Common Stock is 3.560
When was Xeris Biopharma Holdings, Inc. - Common Stock last traded?
The last trade of Xeris Biopharma Holdings, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Xeris Biopharma Holdings, Inc. - Common Stock?
The market capitalization of Xeris Biopharma Holdings, Inc. - Common Stock is 236.73M
How many shares of Xeris Biopharma Holdings, Inc. - Common Stock are outstanding?
Xeris Biopharma Holdings, Inc. - Common Stock has 66.50M shares outstanding.